Sep 28, 2010 12:00am EDT Pieris Signs Broad Collaboration with Sanofi-Aventis and Sanofi Pasteur to Develop Anticalin Therapeutics
Oct 09, 2009 12:00am EDT Pieris reports preclinical development progress of its next generation VEGF antagonist
Feb 03, 2009 12:00am EST Pieris reports development progress for Anticalin® PRS-050, a next generation VEGF antagonist
Jul 16, 2008 12:00am EDT Wacker validates scalability of Anticalin® production with E.coli secretion technology and will produce Pieris first clinical candidate PRS-050
